Non-myeloablative Allogeneic Hematopoietic Stem Cell Transplantation for Adults with Relapsed and Refractory Mantle Cell Lymphoma: A Single Center Analysis in the Rituximab Era

por Mussetti, Alberto, Devlin, Sean M., Castro-Malaspina, Hugo R, Barker, Juliet N., Giralt, Sergio A., Zelenetz, Andrew D., Sauter, Craig S., Perales, Miguel-Angel
Publicado 2015

Anti-SARS-CoV-2 antibody response in patients with chronic lymphocytic leukemia

por Roeker, Lindsey E., Knorr, David A., Pessin, Melissa S., Ramanathan, Lakshmi V., Thompson, Meghan C., Leslie, Lori A., Zelenetz, Andrew D., Mato, Anthony R.
Publicado 2020

Impact of idelalisib on health-related quality of life in patients with relapsed chronic lymphocytic leukemia in a phase III randomized trial

por Ghia, Paolo, Coutre, Steven E., Cheson, Bruce D., Barrientos, Jacqueline C., Hillmen, Peter, Pettitt, Andrew R., Zelenetz, Andrew D., Shreay, Sanatan, Hallek, Michael, Furman, Richard R.
Publicado 2020

Idelalisib addition has neutral to beneficial effects on quality of life in bendamustine/rituximab-treated patients: results of a phase 3, randomized, controlled trial

por Montillo, Marco, Illés, Árpád, Robak, Tadeusz, Pristupa, Alexander S., Wach, Malgorzata, Egyed, Miklós, Delgado, Julio, Jurczak, Wojciech, Morschhauser, Franck, Schuh, Anna, Eradat, Herbert, Shreay, Sanatan, Barrientos, Jacqueline C., Zelenetz, Andrew D.
Publicado 2019

Management of adverse events associated with idelalisib treatment: expert panel opinion

por Coutré, Steven E., Barrientos, Jacqueline C., Brown, Jennifer R., de Vos, Sven, Furman, Richard R., Keating, Michael J., Li, Daniel, O’Brien, Susan M., Pagel, John M., Poleski, Martin H., Sharman, Jeff P., Yao, Nai-Shun, Zelenetz, Andrew D.
Publicado 2015

Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma

por Schatz, Jonathan H., Oricchio, Elisa, Wolfe, Andrew L., Jiang, Man, Linkov, Irina, Maragulia, Jocelyn, Shi, Weiji, Zhang, Zhigang, Rajasekhar, Vinagolu K., Pagano, Nen C., Porco, John A., Teruya-Feldstein, Julie, Rosen, Neal, Zelenetz, Andrew D., Pelletier, Jerry, Wendel, Hans-Guido
Publicado 2011

Urelumab alone or in combination with rituximab in patients with relapsed or refractory B‐cell lymphoma

por Timmerman, John, Herbaux, Charles, Ribrag, Vincent, Zelenetz, Andrew D., Houot, Roch, Neelapu, Sattva S., Logan, Theodore, Lossos, Izidore S., Urba, Walter, Salles, Gilles, Ramchandren, Radhakrishnan, Jacobson, Caron, Godwin, John, Carpio, Cecilia, Lathers, Deanne, Liu, Yali, Neely, Jaclyn, Suryawanshi, Satyendra, Koguchi, Yoshinobu, Levy, Ronald
Publicado 2020

Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse

por Kumar, Anita, Sha, Fushen, Toure, Ahmed, Dogan, Ahmet, Ni, Andy, Batlevi, Connie L., Palomba, Maria Lia M., Portlock, Carol, Straus, David J., Noy, Ariela, Horwitz, Steven M., Moskowitz, Alison, Hamlin, Paul, Moskowitz, Craig H., Matasar, Matthew J., Zelenetz, Andrew D., Younes, Anas
Publicado 2019

Multidimensional Single-Cell Analysis of BCR Signaling Reveals Proximal Activation Defect As a Hallmark of Chronic Lymphocytic Leukemia B Cells

por Palomba, M. Lia, Piersanti, Kelly, Ziegler, Carly G. K., Decker, Hugo, Cotari, Jesse W., Bantilan, Kurt, Rijo, Ivelise, Gardner, Jeff R., Heaney, Mark, Bemis, Debra, Balderas, Robert, Malek, Sami N., Seymour, Erlene, Zelenetz, Andrew D., van den Brink, Marcel R. M., Altan-Bonnet, Grégoire
Publicado 2014

Excellent response to very-low-dose radiation (4 Gy) for indolent B-cell lymphomas: is 4 Gy suitable for curable patients?

por Imber, Brandon S., Chau, Karen W., Lee, Jasme, Lee, Jisun, Casey, Dana L., Yang, Joanna C., Wijentunga, N. Ari, Shepherd, Annemarie, Hajj, Carla, Qi, Shunan, Chelius, Monica R., Hamlin, Paul A., Palomba, M. Lia, Joffe, Erel, Zhang, Zhigang, Zelenetz, Andrew D., Salles, Gilles A., Yahalom, Joachim
Publicado 2021

Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma

por Lin, Richard J., Owens, Colette N., Drill, Esther, Iannotta, Augustine, Oliveros, Mayan, Schick, Dylan L., Noy, Ariela, Gerecitano, John F., Drullinsky, Pamela R., Caron, Philip C., Kumar, Anita, Matasar, Matthew J., Moskowitz, Craig, Korc-Grodzicki, Beatriz, Zelenetz, Andrew D., Salles, Gilles A., Hamlin, Paul A.
Publicado 2021

P1087: PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS AND SUBGROUP ANALYSIS FROM THE PHASE 1/2 BRUIN STUDY WITH >3 YEARS FOLLOW-UP FROM S...

por Jurczak, Wojciech, Luigi Zinzani, Pier, Eyre, Toby A., Cheah, Chan Y., Ujjani, Chaitra S., Izutsu, Koji, MA, Shuo, Flinn, Ian, Alencar, Alvaro J., Lewis, David, Patel, Krish, Maddocks, Kami, Wang, Yucai, Munir, Talha, Zelenetz, Andrew D., Balbas, Minna, Tsai, Donald E., Wang, Chunxiao, Wang, Michael L., Shah, Nirav N.
Publicado 2023

Idelalisib or Placebo in Combination with Bendamustine and Rituximab in Patients with Relapsed/Refractory CLL - Interim Results of a Phase 3 Randomized, Double-blind Placebo-Contro...

por Zelenetz, Andrew D., Barrientos, Jacqueline C., Brown, Jennifer R., Coiffier, Bertrand, Delgado, Julio, Egyed, Miklós, Ghia, Paolo, Illés, Árpád, Jurczak, Wojciech, Marlton, Paula, Montillo, Marco, Morschhauser, Franck, Pristupa, Alexander S., Robak, Tadeusz, Sharman, Jeff P., Simpson, David, Smolej, Lukáš, Tausch, Eugen, Adewoye, Adeboye H., Dreiling, Lyndah K., Kim, Yeonhee, Stilgenbauer, Stephan, Hillmen, Peter
Publicado 2017

Outcomes of Patients with Positive Interim Positron Emission Tomography (PET) Continuing ABVD in the Clinical Setting

por Zheng, Serena, Gupta, Kanika, Goyal, Piyush, Nakajima, Reiko, Michaud, Laure, Batlevi, Connie Lee, Hamlin, Paul A., Horwitz, Steven, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Moskowitz, Craig H., Noy, Ariela, Palomba, M. Lia, Straus, David J., Von Keudell, Gottfried, Falchi, Lorenzo, Yahalom, Joachim, Zelenetz, Andrew D., Younes, Anas, Salles, Gilles, Schöder, Heiko, Joffe, Erel
Publicado 2023

Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse

por Bobillo, Sabela, Joffe, Erel, Sermer, David, Mondello, Patrizia, Ghione, Paola, Caron, Philip C., Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Kumar, Anita, Matasar, Matthew J., Batlevi, Connie L., Moskowitz, Alison, Noy, Ariela, Owens, Collette N., Palomba, M. Lia, Straus, David, von Keudell, Gottfried, Dogan, Ahmet, Zelenetz, Andrew D., Seshan, Venkatraman E., Younes, Anas
Publicado 2021

Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia

por Sharman, Jeff P., Coutre, Steven E., Furman, Richard R., Cheson, Bruce D., Pagel, John M., Hillmen, Peter, Barrientos, Jacqueline C., Zelenetz, Andrew D., Kipps, Thomas J., Flinn, Ian W., Ghia, Paolo, Eradat, Herbert, Ervin, Thomas, Lamanna, Nicole, Coiffier, Bertrand, Pettitt, Andrew R., Ma, Shuo, Tausch, Eugen, Cramer, Paula, Huang, Julie, Mitra, Siddhartha, Hallek, Michael, O’Brien, Susan M., Stilgenbauer, Stephan
Publicado 2019

Follicular lymphoma in the modern era: survival, treatment outcomes, and identification of high-risk subgroups

por Batlevi, Connie L., Sha, Fushen, Alperovich, Anna, Ni, Ai, Smith, Katy, Ying, Zhitao, Soumerai, Jacob D., Caron, Philip C., Falchi, Lorenzo, Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Joffe, Erel, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Moskowitz, Craig H., Noy, Ariela, Owens, Colette, Palomba, Lia M., Straus, David, von Keudell, Gottfried, Zelenetz, Andrew D., Seshan, Venkatraman E., Younes, Anas
Publicado 2020

Clinical outcomes with use of radiation therapy and risk of transformation in early-stage follicular lymphoma

por Sha, Fushen, Okwali, Michelle, Alperovich, Anna, Caron, Philip C., Falchi, Lorenzo, Hamilton, Audrey, Hamlin, Paul A., Horwitz, Steven M., Joffe, Erel, Khan, Niloufer, Kumar, Anita, Matasar, Matthew J., Moskowitz, Alison J., Noy, Ariela, Owens, Colette, Palomba, Lia M., Rodriguez-Rivera, Ildefonso, Straus, David, von Keudell, Gottfried, Zelenetz, Andrew D., Yahalom, Joachim, Dogan, Ahmet, Schöder, Heiko, Seshan, Venkatraman E., Salles, Gilles, Younes, Anas, Batlevi, Connie L.
Publicado 2022

Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular Lymphoma

por Merryman, Reid W., Michaud, Laure, Redd, Robert, Mondello, Patrizia, Park, Hyesun, Spilberg, Gabriela, Robertson, Matthew, Taranto, Eleanor, Ahmed, Gulrayz, Chase, Matthew, Jeter, Erin, Ahn, Inhye E., Brown, Jennifer R., Crombie, Jennifer, Davids, Matthew S., Fisher, David C., Jacobsen, Eric, Jacobson, Caron A., Kim, Austin I., LaCasce, Ann S., Ng, Samuel Y., Odejide, Oreofe O., Parry, Erin M., Salles, Gilles, Zelenetz, Andrew D., Armand, Philippe, Schöder, Heiko, Jacene, Heather
Publicado 2023

Retrospective characterization of nodal marginal zone lymphoma

por Stuver, Robert, Drill, Esther, Qualls, David, Okwali, Michelle, Lee Batlevi, Connie, Caron, Philip C., Dogan, Ahmet, Epstein-Peterson, Zachary D., Falchi, Lorenzo, Hamlin, Paul A., Horwitz, Steven M., Imber, Brandon S., Intlekofer, Andrew M., Johnson, William T., Khan, Niloufer, Kumar, Anita, Lahoud, Oscar B., Lue, Jennifer Kimberly, Matasar, Matthew J., Moskowitz, Alison J., Noy, Ariela, Owens, Colette N., Palomba, M. Lia, Schöder, Heiko, Vardhana, Santosha A., Yahalom, Joachim, Zelenetz, Andrew D., Salles, Gilles, Straus, David J.
Publicado 2023